- Home
- GITS vs CELZ Comparison
GITS vs CELZ Comparison
Compare GITS & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GITS | CELZ |
|---|---|---|
| Founded | 2018 | 1998 |
| Country | South Korea | United States |
| Employees | 12 | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 6.3M |
| IPO Year | N/A | 2008 |
Fundamental Metrics
Financial Performance| Metric | GITS | CELZ |
|---|---|---|
| Price | $1.44 | $2.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 23.6K | ★ 46.6K |
| Earning Date | 05-19-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.08 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $6,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.66 | $1.50 |
| 52 Week High | $7.09 | $6.25 |
Technical Indicators
Market Signals| Indicator | GITS | CELZ |
|---|---|---|
| Relative Strength Index (RSI) | 41.95 | 48.20 |
| Support Level | $1.10 | $2.07 |
| Resistance Level | $2.40 | $2.41 |
| Average True Range (ATR) | 0.15 | 0.13 |
| MACD | 0.03 | -0.01 |
| Stochastic Oscillator | 55.84 | 28.57 |
Price Performance
Historical ComparisonAbout GITS Global Interactive Technologies Inc.
Global Interactive Technologies Inc, formerly Hanryu Holdings Inc is the creator of the engaging social media platform, FANTOO. Through FANTOO, it provides a multi-media platform for its users to interact with other like-minded users, share their appreciation of various types of entertainment and cultures, create their content, enjoy content, and engage in commerce.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.